Recent advances in biomarkers and therapeutic interventions for hepatic drug safety – false dawn or new horizon?
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in biomarkers and therapeutic interventions for hepatic drug safety – false dawn or new horizon?
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages 1-10
Publisher
Informa Healthcare
Online
2016-02-28
DOI
10.1517/14740338.2016.1160057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CSF1 Restores Innate Immunity After Liver Injury in Mice and Serum Levels Indicate Outcomes of Patients With Acute Liver Failure
- (2015) Benjamin M. Stutchfield et al. GASTROENTEROLOGY
- Circulating Kidney Injury Molecule 1 Predicts Prognosis and Poor Outcome in Patients With Acetaminophen-Induced Liver Injury
- (2015) Daniel J. Antoine et al. HEPATOLOGY
- MD-2 is required for disulfide HMGB1–dependent TLR4 signaling
- (2015) Huan Yang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Drug-induced liver injury: Interactions between drug properties and host factors
- (2015) Minjun Chen et al. JOURNAL OF HEPATOLOGY
- Circulating microRNAs: Emerging Biomarkers of Liver Disease
- (2015) Marco Arrese et al. SEMINARS IN LIVER DISEASE
- Methodology to Assess Clinical Liver Safety Data
- (2014) Michael Merz et al. DRUG SAFETY
- Liver Safety Assessment: Required Data Elements and Best Practices for Data Collection and Standardization in Clinical Trials
- (2014) Mark I. Avigan et al. DRUG SAFETY
- The Clinical Liver Safety Assessment Best Practices Workshop: Rationale, Goals, Accomplishments and the Future
- (2014) Paul B. Watkins et al. DRUG SAFETY
- High Mobility Group Box-1 (HMGB1) Participates in the Pathogenesis of Alcoholic Liver Disease (ALD)
- (2014) Xiaodong Ge et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis
- (2014) Peter Huebener et al. JOURNAL OF CLINICAL INVESTIGATION
- Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes
- (2014) V. S. Sabbisetti et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Unknown
- (2014) Daniel Antoine et al. MOLECULAR MEDICINE
- JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation
- (2014) B. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges
- (2014) James W Dear et al. Expert Review of Clinical Pharmacology
- Benign elevations in serum aminotransferases and biomarkers of hepatotoxicity in healthy volunteers treated with cholestyramine
- (2014) Rohit Singhal et al. BMC Pharmacology & Toxicology
- Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans
- (2013) Mitchell R. McGill et al. ARCHIVES OF TOXICOLOGY
- Are we closer to finding biomarkers for identifying acute drug-induced liver injury?
- (2013) Daniel J Antoine et al. Biomarkers in Medicine
- Early detection of paracetamol toxicity using circulating liver microRNA and markers of cell necrosis
- (2013) James W. Dear et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Current Challenges and Controversies in Drug-Induced Liver Injury
- (2013) Alberto Corsini et al. DRUG SAFETY
- Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital
- (2013) Daniel J. Antoine et al. HEPATOLOGY
- Assessment of Emerging Biomarkers of Liver Injury in Human Subjects
- (2013) Shelli Schomaker et al. TOXICOLOGICAL SCIENCES
- Serum Glutamate Dehydrogenase—Biomarker for Liver Cell Death or Mitochondrial Dysfunction?
- (2013) Hartmut Jaeschke et al. TOXICOLOGICAL SCIENCES
- Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice
- (2013) Benjamin L. Woolbright et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Validation of the isolation and quantification of kidney enriched miRNAs for use as biomarkers
- (2012) Jack W. Sharkey et al. BIOMARKERS
- Serum microRNA Biomarkers for Drug-Induced Liver Injury
- (2012) P J Starkey Lewis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future
- (2012) J R Senior CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Effects of Heparins on the Liver: Application of Mechanistic Serum Biomarkers in a Randomized Study in Healthy Volunteers
- (2012) A H Harrill et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis
- (2012) Sanna Nyström et al. EMBO JOURNAL
- Investigative safety science as a competitive advantage for Pharma
- (2012) Jonathan Moggs et al. Expert Opinion on Drug Metabolism & Toxicology
- The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation
- (2012) Mitchell R. McGill et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release
- (2012) Emilie Venereau et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity
- (2012) Daniel J. Antoine et al. JOURNAL OF HEPATOLOGY
- Novel role of PKR in inflammasome activation and HMGB1 release
- (2012) Ben Lu et al. NATURE
- Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs
- (2012) Thomas J. Urban et al. Pharmacogenetics and Genomics
- Research Highlights: Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity
- (2012) Ana Alfirevic et al. PHARMACOGENOMICS
- Mechanism-Based Urinary Biomarkers to Identify the Potential for Aminoglycoside-Induced Nephrotoxicity in Premature Neonates: A Proof-of-Concept Study
- (2012) Stephen J. McWilliam et al. PLoS One
- A Mouse Diversity Panel Approach Reveals the Potential for Clinical Kidney Injury Due to DB289 Not Predicted by Classical Rodent Models
- (2012) Alison H. Harrill et al. TOXICOLOGICAL SCIENCES
- Drug Safety Sciences and the Bottleneck in Drug Development
- (2011) P B Watkins CLINICAL PHARMACOLOGY & THERAPEUTICS
- A generic operational strategy to qualify translational safety biomarkers
- (2011) Katja Matheis et al. DRUG DISCOVERY TODAY
- Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH)
- (2011) Paul B. Watkins et al. DRUG SAFETY
- Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function
- (2011) James A. Thomas et al. HEPATOLOGY
- Plasma MicroRNA-122 as a Biomarker for Viral-, Alcohol-, and Chemical-Related Hepatic Diseases
- (2010) Y. Zhang et al. CLINICAL CHEMISTRY
- Keratin Variants Predispose to Acute Liver Failure and Adverse Outcome: Race and Ethnic Associations
- (2010) Pavel Strnad et al. GASTROENTEROLOGY
- Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method
- (2010) Don C. Rockey et al. HEPATOLOGY
- Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury
- (2010) Lars P. Bechmann et al. JOURNAL OF HEPATOLOGY
- Circulating MicroRNAs: a novel class of biomarkers to diagnose and monitor human cancers
- (2010) Ke Zen et al. MEDICINAL RESEARCH REVIEWS
- Unknown
- (2010) Daniel Antoine et al. MOLECULAR MEDICINE
- Next-generation biomarkers for detecting kidney toxicity
- (2010) Joseph V Bonventre et al. NATURE BIOTECHNOLOGY
- Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies
- (2010) Vishal S Vaidya et al. NATURE BIOTECHNOLOGY
- Serum Metabolomics Reveals Irreversible Inhibition of Fatty Acid β-Oxidation through the Suppression of PPARα Activation as a Contributing Mechanism of Acetaminophen-Induced Hepatotoxicity
- (2009) Chi Chen et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans
- (2009) A. H. Harrill et al. GENOME RESEARCH
- Circulating microRNAs, potential biomarkers for drug-induced liver injury
- (2009) K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Mobility Group Box-1 Protein and Keratin-18, Circulating Serum Proteins Informative of Acetaminophen-Induced Necrosis and Apoptosis In Vivo
- (2009) Daniel J. Antoine et al. TOXICOLOGICAL SCIENCES
- Mechanism-based bioanalysis and biomarkers for hepatic chemical stress
- (2009) D.J. Antoine et al. XENOBIOTICA
- Using controlled clinical trials to learn more about acute drug-induced liver injury
- (2008) Paul B. Watkins et al. HEPATOLOGY
- Preclinical evaluation of M30 and M65 ELISAs as biomarkers of drug induced tumor cell death and antitumor activity
- (2008) J. Cummings et al. MOLECULAR CANCER THERAPEUTICS
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- The current state of serum biomarkers of hepatotoxicity
- (2007) Josef Ozer et al. TOXICOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started